Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy.
暂无分享,去创建一个
Dieter Mesotten | G. Van den Berghe | J. Swinnen | Greet Van den Berghe | Pieter J Wouters | D. Mesotten | P. Wouters | F. Vanderhoydonc | Frank Vanderhoydonc | Johannes V Swinnen
[1] J. Silvius,et al. Role of cholesterol in lipid raft formation: lessons from lipid model systems. , 2003, Biochimica et biophysica acta.
[2] G. Van den Berghe,et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. , 2003, The Journal of clinical endocrinology and metabolism.
[3] O. McGuinness,et al. Infection impairs insulin-dependent hepatic glucose uptake during total parenteral nutrition. , 2003, American journal of physiology. Endocrinology and metabolism.
[4] Miet Schetz,et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.
[5] G. Van den Berghe,et al. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. , 2002, The Journal of clinical endocrinology and metabolism.
[6] P. Kwiterovich. Lipoprotein heterogeneity: diagnostic and therapeutic implications. , 2002, The American journal of cardiology.
[7] R. Zechner,et al. Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism , 2002, Current opinion in lipidology.
[8] K. Petersen,et al. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. , 2002, The American journal of cardiology.
[9] L. Råstam,et al. Survival in patients with type 2 diabetes in a Swedish community: skaraborg hypertension and diabetes project. , 2002, Diabetes care.
[10] Joseph L Goldstein,et al. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.
[11] Y. Carpentier,et al. Changes in the concentration and composition of plasma lipoproteins during the acute phase response , 2002, Current opinion in clinical nutrition and metabolic care.
[12] H. Harris,et al. Endogenous lipoproteins impact the response to endotoxin in humans , 2002, Critical care medicine.
[13] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[14] K. Feingold,et al. In Vivo and in Vitro Regulation of Sterol 27-Hydroxylase in the Liver during the Acute Phase Response , 2001, The Journal of Biological Chemistry.
[15] M. Foretz,et al. Sterol-regulatory-element-binding protein 1c mediates insulin action on hepatic gene expression. , 2001, Biochemical Society transactions.
[16] Y. Deshaies,et al. Nitric oxide mediates endotoxin‐induced hypertriglyceridemia through its action on skeletal muscle lipoprotein lipase , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] K. Feingold,et al. Infection and inflammation-induced proatherogenic changes of lipoproteins. , 2000, The Journal of infectious diseases.
[18] R. Wolfe,et al. Changes in Intermediary Metabolism in Severe Surgical Illness , 2000, World Journal of Surgery.
[19] A. García-de-Lorenzo,et al. Hypocholesterolemia in critically ill patients , 2000, Intensive Care Medicine.
[20] F. Giuliante,et al. Pathophysiologic correlates of hypocholesterolemia in critically ill surgical patients , 1999, Intensive Care Medicine.
[21] M. Magnuson,et al. Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase* , 1999, The Journal of Biological Chemistry.
[22] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[23] C. Klein,et al. Overfeeding macronutrients to critically ill adults: metabolic complications. , 1998, Journal of the American Dietetic Association.
[24] I. Shimomura,et al. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. , 1997, The Journal of clinical investigation.
[25] A. Gaetano,et al. Hypocholesterolemia and risk of death in the critically ill surgical patient , 1996, Intensive Care Medicine.
[26] F. Bosch,et al. Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] P. Barie,et al. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. , 1996, Critical care medicine.
[28] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[29] R. Krauss,et al. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. , 1993, The Journal of clinical endocrinology and metabolism.
[30] H. Harris,et al. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. , 1993, The Journal of clinical investigation.
[31] K. Feingold,et al. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. , 1992, Journal of lipid research.
[32] S. Wong,et al. Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat. , 1992, Biochimica et biophysica acta.
[33] H. Harris,et al. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. , 1990, The Journal of clinical investigation.
[34] T. Nouspikel,et al. Transcriptional induction of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon-cAMP system. , 1989, The Journal of biological chemistry.
[35] P. Edwards,et al. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[36] W. Knaus,et al. APACHE II: a severity of disease classification system. , 1985 .
[37] J. F. Henning,et al. Patterns and problems of adult total parenteral nutrition use in US academic medical centers. , 1998, Archives of surgery.
[38] L. Lind,et al. Impaired glucose and lipid metabolism seen in intensive care patients is related to severity of illness and survival. , 1994, Clinical intensive care : international journal of critical & coronary care medicine.